中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2013, Vol. 48 Issue (2) :152-154    DOI:
ҩ�����ٴ� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << | >>
��֢�໤���ٴ�ҩʦ�������ܲ�ȫ���ߵ�ҩѧ�໤
�������
�㽭��ѧҽѧԺ�������ݷ�ҽԺ������ 310016

Download: PDF (0KB)   HTML (1KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ�� ͨ��������Ժ��֢�໤��(ICU)�ٴ�ҩʦ�������ܲ�ȫ���ߵ�ҩѧ���񣬽����ٴ�ʵ����ᣬΪ����ٴ�ҩʦ�ṩ����� ���� ͨ������1���������������ܲ�ȫ���껼�ߵ�������״�����Ƚ�������ʽ����Cockcoft-Gault ��ʽ�ͼ򻯵�MDRD��ʽ�����������ܷ���������ԡ� ��� ����������״��ʱӦ���ݻ��ߵľ���������ò�ͬ�ķ������������������ܲ�ȫ�����껼��ʹ��MDRD��ʽ��Ϊ���� ���� ��֢�໤���ٴ�ҩʦӦ���й�ע���ߵ�������״������������Ϊ��Ҫ��й;����ҩ��Ӧ��ʱ�������������������������Ϊ�ٴ��ṩ��������ҩѧ����
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
����
����
�ؼ����� �ٴ�ҩʦ   ��֢�໤��   �����ܲ�ȫ   ҩѧ�໤     
Abstract��
Keywords��   
�ո�����: 2012-03-20;
��������:�㽭ʡ������������Ŀ��Y201121395��
���߼��: ���Ů����ʿ��������ҩʦ �о������ٴ�ҩѧ Tel/Fax����0571��86006809 E-mail��zhaorui1999@yahoo.com.cn
���ñ���:   
����, ���� .��֢�໤���ٴ�ҩʦ�������ܲ�ȫ���ߵ�ҩѧ�໤[J]  �й�ҩѧ��־, 2013,V48(2): 152-154
ZHAO Rui, MA Ke .[J]  Chinese Pharmaceutical Journal, 2013,V48(2): 152-154
��
[1] DIONNE R E�� BAUER L A�� GIBSON G A �� et al. Estimating creatinine clearance in morbidity obese patients.Am J Hosp Pharm�� 1981�� 38(6)��841-844.
[2] Media Center. Cancer�� World Health Organization�� 2012�� 2.http��//www.who.int/mediacentre/factsheets/fs297/en/
[3] Ministry of Health of the People's Republic of China. The Third National inquest.http��//www.moh.gov.cn/publicfiles/business/htmlfiles/wsb/pxwfb/200804/33517.htm.
[4] ZHOU X Y�� PENG W Q. Marketing stats analysis for antineoplastic angents. Med Inf(ҽѧ��Ϣ)��2007 ��9(20)�� 1555-1557.
[5] IMS Health Database��2011��. . Antimeoplastic drugs. http��//www.imshealth.com/portal/site/ims.
[6] SU D S. Industrial Economics(��ҵ����ѧ). Vol 1. Beijing�� Higher Education Press�� 2000�� 126.
[7] Boston Consulting Group. BCG Matrix. http��//baike. baidu. com/view/1332420. htm.
[8] Dabur Pharmaceuticals Will be Listed in the United States as a generic version of Pfizer Camptosar . http��//www.healthoo.com/A9/200711/A9_20071102104942_332385.asp��2007-11-02/2011-07-01.[8]
[9] The Application for Listing of Bendamustine in America. http��//www.healthoo.com/A8/200709/A8_20070926093515_330165.asp��2007-09-26/2011-07-01
[10] BJORNSSON T D. Use of serum creatinine concentrations to determine renal function. Clin Pharmacokinet�� 1979�� 4(3)�� 200-222.
[11] XIE J�� TAN F. Advances in studies on antitumor drugs originated from plant . Chin Trad Her Drugs(�в�ҩ)�� 2007�� 38(2)�� 285-287.
[12] MYERS G L�� MILLER W G�� CORESH J�� et al. Recommendations for improving serum creatinine measurement�� A report from the laboratory working group of the national kidney disease education program. Clin Chem�� 2006�� 52(1)�� 5-18.
[13] LEVEY A S�� CORESH J�� GREENE T�� et al. Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J Am Soc Nephrol�� 2005�� 16�� 69A.
[14] LEVEY A S�� BOSCH J P�� LEWIS J B�� et al. A more accurate method to estimate glomerular filtration rate from serum creatinine�� A new prediction equation. Ann Intern Med�� 1999�� 130(6)�� 461-470.
[15] LEVEY A S�� GREENE T�� KUSEK J�� et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol�� 2000�� 11�� 155A.
[16] FROISSART M�� ROSSERT J�� JACQUOT C�� et al. Predictive performance of the modification of diet in renal disease and cockcroft-gault equations for estimating renal function. J Am Soc Nephrol�� 2005�� 16(4)�� 763-773.
[17] VERHAVE J C�� FESLER P�� RIBSTEIN J�� et al. Estimation of renal function in subjects with normal serum creatinine levels�� Inf-luence of age and body mass index. Am J Kidney Dis�� 2005�� 46(2)�� 233-241.
[18] CIRILLO M�� ANASTASIO P�� DE SANTO N G. Relationship of gender�� age�� and body mass index to errors in predicted kidney function. Nephrol Dial Transplant�� 2005�� 20(9)�� 1791-1798.
[19] POGGIO E D�� WANG X�� GREENE T�� et al. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol�� 2005�� 16(2)�� 459-466.
[20] ZHANG L�� ZHAI S D. Pharmacy and pharmaceutical care for cardiovascular inpatients. Chin Pharm J (�й�ҩѧ��־)��2008�� 43(24)�� 1923-1924.
[21] ZHAO Y S�� ZHAI S D. Hospital pharmacy and evidence-based pharmacy. Chin Pharm J(�й�ҩѧ��־)��2007��42(24)�� 1922-1924.
[1] �ܹ��� �պ� ��ȫӢ ���ı� ��ΰ��.һ��ҩԴ������ɭ�ۺ����ķ��������[J]. �й�ҩѧ��־, 2012,47(7): 565-566
[2] ����.���ڿ��ٴ�ҩʦ�������[J]. �й�ҩѧ��־, 2012,47(5): 391-392
[3] �����������ɣ�ʷ���ң���־��.�ٴ�ҩʦ���������ҩ������ʵ��[J]. �й�ҩѧ��־, 2012,47(19): 1600-1603
[4] ������.�ٴ�ҩʦ���������ڿ��ٴ�����Ⱦ���ư�������[J]. �й�ҩѧ��־, 2012,47(12): 1012-1013
[5] ����a;������b;����a;�Ŵ�a;������a;������a.�ٴ�ҩʦ����1�������ް����߻��Ƶ�ҩѧʵ��[J]. �й�ҩѧ��־, 2012,47(11): 875-877
[6] ������;����Ө;����;����;����Ҷ;��ΰ.1������ֲ���ŧ�׻����������Ƶ�ҩѧ�໤[J]. �й�ҩѧ��־, 2012,47(10): 802-804
[7] �̺��� ������ ���� ����ΰ ��ǿ �Ӣ ������.�ٴ�ҩʦ���벡��ҩ��ҩѧ�����ǰ������о�[J]. �й�ҩѧ��־, 2011,46(9): 716-717
[8] ��־��.���ӻ���ҽԺҩѧ�����е�Ӧ��[J]. �й�ҩѧ��־, 2011,46(4): 311-312
[9] ���� ������ ������ �Ŵ��� �˽�.ȥ�����ù����SICU��֢���ߵ�ҩ��ѧ[J]. �й�ҩѧ��־, 2011,46(3): 221-223
[10] ������ ������ �ƺ첨.��ר��ҽԺ��չҩѧ�����̽�ּ����[J]. �й�ҩѧ��־, 2011,46(15): 1212-1212
[11] Ԭ��� �Ų� ÷��.������ҩ������������ҩ����[J]. �й�ҩѧ��־, 2011,46(12): 966-968
[12] ���� ���� ����.�����ڿ��ٴ�ҩʦ��������̽��[J]. �й�ҩѧ��־, 2010,45(23): 1874-1876
[13] ��ӱ ���� �Ź��� ���޻�.����ר��ҽԺ���ٴ�ҩʦ����ʵ��[J]. �й�ҩѧ��־, 2010,45(23): 1868-1870
[14] ���� ����Т ������.�ٴ�ҩʦ�ں����ڿƵ�ҩѧ����ʵ��[J]. �й�ҩѧ��־, 2010,45(20): 1599-1600
[15] �ֽ���;������ . ҩʦЭ���ٴ���ù�����Ʋ�����ҩѧ�໤��ʵ����Ч��[J]. �й�ҩѧ��־, 2009,44(24): 1942-1943
Copyright 2010 by �й�ҩѧ��־